A therapeutic role for mesenchymal stem cells in acute lung injury independent of hypoxia-induced mitogenic factor

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 2, 2012, Pages 376-385

  Song, Lin ^a   Xu, Jinfu ^b   Qu, Jieming ^a   Sai, Yin ^c   Chen, Chunmei ^c   Yu, Long ^c   Li, Dechun ^d   Guo, Xuejun ^e  

^a FUDAN UNIVERSITY   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^c FUDAN UNIVERSITY   (China)

^d SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Acute lung injury; Fibrosis; Hypoxia induced mitogenic factor; Mesenchymal stem cells; Transplantation

Indexed keywords

ACTIN; ALPHA SMOOTH MUSCLE ACTIN, MOUSE; ALPHA-SMOOTH MUSCLE ACTIN, MOUSE; CYTOKINE; HYDROXYPROLINE; LIPOPOLYSACCHARIDE; RETNLA PROTEIN, MOUSE; SIGNAL PEPTIDE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE LUNG INJURY; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BONE MARROW CELL; CHEMICALLY INDUCED DISORDER; FIBROSIS; IMMUNOLOGY; LUNG; LUNG EDEMA; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; MOUSE; PATHOLOGY; PNEUMONIA;

ACTINS; ACUTE LUNG INJURY; ANIMALS; BONE MARROW CELLS; CYTOKINES; FIBROSIS; HYDROXYPROLINE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPOPOLYSACCHARIDES; LUNG; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; PNEUMONIA; PULMONARY EDEMA; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 84863044997     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2011.01326.x     Document Type: Article

References (23)

1. Brigham KL, Meyrick B. Endotoxin and lung injury. Am Rev Respir Dis. 1986; 133: 913-27.
2. Jeyaseelan S, Chu HW, Young SK, et al Transcriptional profiling of lipopolysaccharide-induced acute lung injury. Infect Immun. 2004; 72: 7247-56.
3. Lee SH, Jang AS, Kim YE, et al Modulation of cytokine and nitric oxide by mesenchymal stem cell transfer in lung injury/fibrosis. Respir Res. 2010; 11: 16-30.
4. Wang D, Morales JE, Calame DG, et al Transplantation of human embryonic stem cell-derived alveolar epithelial type II cells abrogates acute lung injury in mice. Mol Ther. 2010; 18: 625-34.
5. Wary KK, Vogel SM, Garrean S, et al Requirement of alpha(4)beta(1) and alpha(5)beta(1) integrin expression in bone-marrow-derived progenitor cells in preventing endotoxin-induced lung vascular injury and edema in mice. Stem Cells. 2009; 27: 3112-20.
6. Wagner KF, Hellberg AK, Balenger S, et al Hypoxia-induced mitogenic factor has antiapoptotic action and is upregulated in the developing lung: coexpression with hypoxia-inducible factor-2 alpha. Am J Respir Cell Mol Biol. 2004; 31: 276-82.
7. Renigunta A, Hild C, Rose F, et al Human relmbeta is a mitogenic factor in lung cells and induced in hypoxia. FEBS Lett. 2006; 580: 900-3.
8. Teng X, Li D, Champion HC, et al FIZZ1/RELM alpha, a novel hypoxia-induced mitogenic factor in lung with vasoconstrictive and angiogenic properties. Circ Res. 2003; 92: 1065-7.
9. Tong Q, Zheng L, Dodd-o J, et al Hypoxia-induced mitogenic factor modulates surfactant protein B and C expression in mouse lung. Am J Respir Cell Mol Biol. 2006; 34: 28-38.
10. Yamaji-Kegan K, Su Q, Angelini DJ, et al Hypoxia-induced mitogenic factor has proangiogenic and proinflammatory effects in the lung via VEGF and VEGF receptor-2. Am J Physiol Lung Cell Mol Physiol. 2006; 291: L1159-68.
11. Gupta N, Su X, Popov B, et al Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol. 2007; 179: 1855-63.
12. Wagner EM, Sánchez J, McClintock JY, et al Inflammation and ischemia-induced lung angiogenesis. Am J Physiol Lung Cell Mol Physiol. 2008; 294: L351-7.
13. Takao Y, Mikawa K, Nishina K, et al Attenuation of acute lung injury with propofol in endotoxemia. Anesth Analg. 2005; 100: 810-6.
14. Meirelles Lda S, Nardi NB. Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion, and characterization. Br J Haematol. 2003; 123: 702-11.
15. Grove JE, Lutzko C, Priller J, et al Marrow-derived cells as vehicles for delivery of gene therapy to pulmonary epithelium. Am J Respir Cell Mol Biol. 2002; 27: 645-51.
16. Zhang XY, La Russa VF, Bao L, et al Lentiviral vectors for sustained transgene expression in human bone marrow-derived stromal cells. Mol Ther. 2002; 5: 555-65.
17. Mei SH, Haitsma JJ, Dos Santos CC, et al Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. Am J Respir Crit Care Med. 2010; 182: 1047-57.
18. Qi Y, Qian L, Sun B, et al Circulating CD34(+) cells are elevated in neonates with respiratory distress syndrome. Inflamm Res. 2010; 59: 889-95.
19. Brody AR, Salazar KD, Lankford SM. Mesenchymal stem cells modulate lung injury. Proc Am Thorac Soc. 2010; 7: 130-3.
20. Dominici M, Le Blanc K, Mueller I, et al Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8: 315-7.
21. Tong Q, Zheng L, Lin L, et al Hypoxia-induced mitogenic factor promotes vascular adhesion molecule-1 expression via the PI-3K/Akt-NF-kappaB signaling pathway. Am J Respir Cell Mol Biol. 2006; 35: 444-56.
22. Zhang K, Rekhter MD, Gordon D, et al Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study. Am J Pathol. 1994; 145: 114-25.
23. Liu T, Dhanasekaran SM, Jin H, et al FIZZ1 stimulation of myofibroblasts differentiation. Am J Pathol. 2004; 164: 1315-26.